An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825

BACKGROUND. Glioblastoma (GBM) is the most common primary malignant brain tumor. Nomograms are often used for individualized estimation of prognosis. This study aimed to build and independently validate a nomogram to estimate individualized survival probabilities for patients with newly diagnosed GB...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Gittleman, Haley, Lim, Daniel, Kattan, Michael W., Chakravarti, Arnab, Gilbert, Mark R., Lassman, Andrew B., Lo, Simon S., Machtay, Mitchell, Sloan, Andrew E., Sulman, Erik P, Tian, Devin, Vogelbaum, Michael A., Wang, Tony J. C., Penas-Prado, Marta, Youssef, Emad, Blumenthal, Deborah T., Zhang, Peixin, Mehta, Minesh P., Barnholtz-Sloan, Jill S.
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2017
Materias:
Clinical Investigations
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5464437/
https://ncbi.nlm.nih.gov/pubmed/28453749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now208
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares